Genetic and molecular biology of gastric cancer among Iranian patients: an update

5Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: There is a declining trend of gastric cancer (GC) incidence in the world during recent years that is related to the development of novel diagnostic methods. However, there is still a high ratio of GC mortality among the Iranian population that can be associated with late diagnosis. Despite various reports about the novel diagnostic markers, there is not any general and standard diagnostic panel marker for Iranian GC patients. Therefore, it is required to determine an efficient and general panel of molecular markers for early detection. Main body of the abstract: In the present review, we summarized all of the reported markers until now among Iranian GC patients to pave the way for the determination of a population-based diagnostic panel of markers. In this regard, we categorized these markers in different groups based on their involved processes to know which molecular process is more frequent during the GC progression among Iranians. Conclusion: We observed that the non-coding RNAs are the main factors involved in GC tumorigenesis in this population.

Cite

CITATION STYLE

APA

Abbaszadegan, M. R., Mojarrad, M., Rahimi, H. R., & Moghbeli, M. (2022, December 1). Genetic and molecular biology of gastric cancer among Iranian patients: an update. Egyptian Journal of Medical Human Genetics. Springer Science and Business Media Deutschland GmbH. https://doi.org/10.1186/s43042-022-00232-w

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free